Assyro AI

Orange Book product · Generic (ANDA)

SILODOSIN

SILODOSIN

Generic (ANDA)ANDA 210396DISCN TORRENT
View SILODOSIN familyOpen on FDA Orange Book

At a glance

Feb 10, 2025

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 10, 2025

    1 yr 4 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

SILODOSIN

Strength

4MG

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

ANDA 210396

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of SILODOSIN

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo